skip navigation

Justinfo Subscribe to Stay Informed

Add your conference to our Justice Events calendar


NCJRS Abstract


Subscribe to Stay Informed
Want to be in the know? JUSTINFO is a biweekly e-newsletter containing information about new publications, events, training, funding opportunities, and Web-based resources available from the NCJRS Federal sponsors. Sign up to get JUSTINFO in your inbox.

The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
NCJ Number: NCJ 217269     Find in a Library
Title: Evaluation of Prescription Drug Monitoring Programs
  Document URL: PDF 
  Agency Summary: Agency Summary 
Author(s): Ronald Simeone ; Lynn Holland
Corporate Author: Simeone Associates, Inc.
United States of America
Date Published: 09/2006
Page Count: 46
  Annotation: This study examined the direct and indirect effects of Prescription Drug Monitoring Programs (PDMPs) on the supply and abuse of prescription drugs.
Abstract: Study findings suggest that the presence of a Prescription Drug Monitoring Program (PDMP) reduces per capita supply of prescription pain relievers and stimulants which in turn reduces the probability of abuse for such drugs. The results also suggest that States which are proactive in their approach to regulation may be more effective in reducing the per capita supply of prescription pain relievers and stimulants than States which are reactive in their approach to regulation. In conclusion, the results from the aggregate and individual response models indicate that PDMPs inhibited growth in prescription sales for pain relievers and stimulants, and in doing so, exerted an indirect effect on the probability of abuse for these drugs. The introduction of measures of price per gram for pure heroin, cocaine, crack, and methamphetamine in the model would be instructive, and an examination of possible substitution effects in greater detail. Twenty States have implemented systems to monitor the prescription and sale of drugs identified as controlled substances by the Drug Enforcement Administration (DEA), and 23 States are in the process of designing or planning to design such systems. PDMPs are all intended ultimately to reduce the abuse of controlled pharmaceutical substances. Tables, figures, and references
Main Term(s): Prescription drugs
Index Term(s): Drug abuse ; Drug regulation ; Drug law enforcement ; Controlled Substances ; Illegal dispensing of licit drugs ; Pharmacy crimes ; BJA grant-related documents
Sponsoring Agency: Bureau of Justice Assistance
US Dept of Justice
Office of Justice Programs
United States of America
Grant Number: 2005-PM-BX-K189
Sale Source: Simeone Associates, Inc.
220 Lancaster Street
Albany, NY 12210-1132
United States of America
Type: Program/Project Evaluation
Country: United States of America
Language: English
Note: Downloaded on February 6, 2007.
  To cite this abstract, use the following link:

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.